ELV watch $291.41-295.59: Double Golden zone could mark BOTTOM ELV and all health insurance stocks have been dumping.
This is trying to break Double Golden zone $291.43-295.59
Looking for a Break-n-Retest for possible long entries.
11,884.015
0.027 BRL
32.24 B BRL
953.17 B BRL
About Elevance Health, Inc.
Sector
Industry
CEO
Gail Koziara Boudreaux
Website
Headquarters
Indianapolis
Founded
1944
ISIN
BRE1LVBDR002
FIGI
BBG00R4Z5100
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Related stocks
Elevance is losing the long term trendlineLosing such a large trendline is always a bad signal for a company.
The price can easily fall from 15 to 25% in the upcoming weeks or months, take care with this stock unless you are shorting.
This is especially significant while we are seeing Indexs, BTC and more doing new all time highs.
A SL
Potential 33% gain in ELVELV has a potential for a reversal for potentially 33% gain.
Using the Data Distribution with Extreme Clusters custom indicator, we can see that the stock is overextended on both the 5D chart (longer term) and 1D (shorter term) chart.
The last weekly bar ended up on a very high volume. Looking a
BUY ELVHealth Industry stocks have fallen a lot, ELV being one of many. Buying this stock at this current level anticipating price to respect this demand level.
Support Levels approaching$250 could potentially be a good opportunity to pick up Elevance. We are moving towards that level and I will be patient here as the downtrend is strong. The stock is representing deep value here and insiders agree as the CEO is been acquiring shares.
The stock has dropped 50% since it's recent hi
OVERSOLDLooking for back over 300 quickly CEO just $2.44 million strong Q2 revenue growth of 14.3% year-over-year to $49.42 billion, revenue is as good as it was at 500$ but expenses have been high. Institutions are loading here, good long-term hold if we need to continue DCA.
Elevance Health | ELV | Long at $286.00What are seeing in the healthcare and health insurance provider industry right now is destruction before a once-in-a-lifetime boom. The baby boomer generation is between 60 and 79 right now and the amount of healthcare service that will be needed to serve that population is staggering. Institutions
ELV (Elevance Health) – Catching the Knife or Catching Value?Elevance (ELV) just took a 12% hit after Q2 earnings missed estimates and full-year guidance was cut significantly. But here's the thing—the selloff may be overdone. The stock now trades at a forward P/E of ~10, well below industry peers, and is approaching multi-year support levels.
📥 Entry Plan
$ELV, Long, TP>10-15%NYSE:ELV , Long, TP>10-15%
Fundamentally the stock is good.
Choose an entry point and do not forget about a protective order if you are trading with leverage.
Don't risk it if you're not sure.
Good luck to everyone.
ELV Swing Trade Setup - May 2025Fundamentally undervalued with a strong balance sheet, consistent earnings beats, and a low P/E ratio. Recent drop (~33% from 52-week highs) appears overdone relative to earnings strength likely due to short-term Medicaid cost concerns, not long-term deterioration.
📊 Position Type:
✅ Swing Trade t
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ANTM3667634
Elevance Health, Inc. 5.85% 15-JAN-2036Yield to maturity
—
Maturity date
Jan 15, 2036
ELVH5534358
Elevance Health, Inc. 4.75% 15-FEB-2033Yield to maturity
—
Maturity date
Feb 15, 2033
ANTM4880743
Elevance Health, Inc. 2.875% 15-SEP-2029Yield to maturity
—
Maturity date
Sep 15, 2029
ANTM5495609
Elevance Health, Inc. 6.1% 15-OCT-2052Yield to maturity
—
Maturity date
Oct 15, 2052
ANTM4606236
Anthem, Inc. /Old/ 4.55% 01-MAR-2048Yield to maturity
—
Maturity date
Mar 1, 2048
ANTM4983288
Elevance Health, Inc. 3.125% 15-MAY-2050Yield to maturity
—
Maturity date
May 15, 2050
ANTM3707029
Elevance Health, Inc. 5.95% 15-DEC-2034Yield to maturity
—
Maturity date
Dec 15, 2034
ELVH5534305
Elevance Health, Inc. 5.125% 15-FEB-2053Yield to maturity
—
Maturity date
Feb 15, 2053
ANTM4153492
Elevance Health, Inc. 4.85% 15-AUG-2054Yield to maturity
—
Maturity date
Aug 15, 2054
ANTM4606305
Elevance Health, Inc. 4.101% 01-MAR-2028Yield to maturity
—
Maturity date
Mar 1, 2028
ANTM5923069
Elevance Health, Inc. 4.5% 30-OCT-2026Yield to maturity
—
Maturity date
Oct 30, 2026
See all E1LV34 bonds